| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 126 |
| 1 | METHOTREXATE SODIUM | 69 |
| 2 | METHOTREXATE | 65 |
| 3 | PREDNISOLONE | 61 |
| 4 | PREDNISOLONE ORAL | 61 |
| 5 | PREDNISOLONE ORAL SOLUTION | 61 |
| 6 | ADALIMUMAB | 43 |
| 7 | ISONIAZID | 35 |
| 8 | GOLIMUMAB | 29 |
| 9 | PYRAZINAMIDE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIFUNGAL LIQUID SPRAY | 1 | 0.0053 |
| 1 | AURANOFIN | 1 | 0.0049 |
| 2 | TOLNAFTATE 1% | 1 | 0.0034 |
| 3 | ETHAMBUTOL HYDROCHLORIDE | 8 | 0.0029 |
| 4 | STREPTOMYCIN | 3 | 0.0026 |
| 5 | PYRAZINAMIDE | 22 | 0.0023 |
| 6 | GOLIMUMAB | 29 | 0.0023 |
| 7 | MIRIKIZUMAB-MRKZ | 2 | 0.0022 |
| 8 | ISONIAZID | 35 | 0.0021 |
| 9 | RIFAMPICIN | 21 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 187 |
| 1 | Corticosteroid [EPC] | 98 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 68 |
| 3 | Antimycobacterial [EPC] | 41 |
| 4 | Aminosalicylate [EPC] | 30 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 6 | Proton Pump Inhibitor [EPC] | 24 |
| 7 | Platinum-based Drug [EPC] | 14 |
| 8 | Vitamin B12 [EPC] | 14 |
| 9 | Vitamin C [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimycobacterial [EPC] | 41 | 0.0017 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 2 | Reducing and Complexing Thiol [EPC] | 1 | 0.0004 |
| 3 | Rifamycin Antibacterial [EPC] | 11 | 0.0003 |
| 4 | Aminosalicylate [EPC] | 30 | 0.0003 |
| 5 | Oxazolidinone Antibacterial [EPC] | 9 | 0.0003 |
| 6 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 8 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 9 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |